Foundation for Sarcoidosis Research Announces 3 New Members to the 40 Member FSR Global Sarcoidosis Clinic Alliance through its FSR-GSCA Capacity Building Grants
November 01, 2023 11:26 ET
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research announces three clinics that have been selected as members of FSR Global Sarcoidosis Clinic Alliance
Molecure Announces First Half 2023 Results – Significant Financial and Operating Momentum
September 29, 2023 06:00 ET
|
Molecure
Molecure strategy update for 2023-2025 based on the development of a diversified portfolio of innovative research projects with the potential for breakthrough therapies for incurable diseasesCompleted...
Foundation for Sarcoidosis Research announces largest Global Sarcoidosis Virtual Summit – Find Your Community, Find Your Life
September 26, 2023 09:15 ET
|
Foundation for Sarcoidosis Research
Foundation for Sarcoidosis Research to Host Largest Virtual Sarcoidosis Educational Event of the Year
Foundation for Sarcoidosis Research partners with 95 Walgreens stores in Alabama to raise awareness of sarcoidosis and the importance of all impacted by heart and lung disease to get vaccinated
September 15, 2023 15:23 ET
|
Foundation for Sarcoidosis Research
CHICAGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Beginning September 16th, Walgreens, a pharmacy and retail leader who plays a critical role in the U.S. healthcare system by providing a wide range of...
Foundation for Sarcoidosis Research Graduates Second Class of New Volunteers from 11 States to Raise Awareness and Improve Clinical Outcomes for Those Living with Sarcoidosis
September 12, 2023 10:42 ET
|
Foundation for Sarcoidosis Research
CHICAGO, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Foundation for Sarcoidosis Research (FSR), the leading international nonprofit organization dedicated to finding a cure and improving care for sarcoidosis...
aTyr Pharma Presents Efzofitimod Data Demonstrating Statistically Significant Improvements in Time to Relapse, FVC and Patient Reported Outcomes
September 11, 2023 08:00 ET
|
aTyr Pharma, Inc.
Post-hoc analysis from Phase 1b/2a study in pulmonary sarcoidosis presented at the European Respiratory Society (ERS) International Congress 2023. 7.7% of patients in the 3.0 and 5.0 mg/kg...
Foundation for Sarcoidosis Research Awards Dr. Christen Vagts, University of Illinois Hospital and Clinic, Fellowship Grant for 2023–2025
July 25, 2023 17:03 ET
|
Foundation for Sarcoidosis Research
CHICAGO, July 25, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce that the FSR Sarcoidosis Research Fellowship for 2023-2025 is being awarded to Dr....
The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch
July 24, 2023 09:00 ET
|
Molecure
Press release The U.S. Food and Drug Administration Gives the Green Light to Molecure’s Flagship Program – Phase II Clinical Testing of OATD-01 is Ready for Launch Molecure can proceed with clinical...
Foundation for Sarcoidosis Research Appoints Two New Members, Calvin Harris Jr., CPA and Joel D. Rosen, Esq., to Board of Directors
July 13, 2023 14:39 ET
|
Foundation for Sarcoidosis Research
CHICAGO, July 13, 2023 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) is pleased to announce the appointment of Calvin Harris Jr., CPA and Joel D. Rosen, Esq. to the FSR Board of...
Foundation for Sarcoidosis Research Releases White Paper and Hosts Congressional Briefing on Advancing Clinical Trial Equity for Black Patients with Sarcoidosis
May 22, 2023 10:15 ET
|
Foundation for Sarcoidosis Research
CHICAGO, May 22, 2023 (GLOBE NEWSWIRE) -- Foundation for Sarcoidosis Research (FSR), the leading international organization dedicated to elevating research, raising awareness and providing support...